Brevan Howard Capital Management’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$641K Sell
10,446
-50,060
-83% -$3.58M 0.01% 1157
2025
Q4
$5.02M Buy
60,506
+10,171
+20% +$761K 0.05% 240
2025
Q3
$3.38M Buy
50,335
+5,377
+12% +$389K 0.02% 360
2025
Q2
$3.51M Buy
44,958
+36,374
+424% +$2.79M 0.02% 507
2025
Q1
$657K Buy
+8,584
New +$699K 0.01% 643
2024
Q4
Sell
-7,928
Closed -$612K 1111
2024
Q3
$612K Sell
7,928
-3,058
-28% -$228K ﹤0.01% 625
2024
Q2
$747K Buy
+10,986
New +$745K 0.01% 472
2024
Q1
Sell
-18,635
Closed -$1.41M 1064
2023
Q4
$1.41M Buy
18,635
+10,718
+135% +$740K 0.02% 169
2023
Q3
$536K Buy
+7,917
New +$546K 0.01% 158

Other funds holding CTSH

Brevan Howard Capital Management's CTSH Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Cognizant (CTSH) stake by 83% in Q1 2026, selling an estimated $3.58M and leaving 10,446 shares worth $641K. The position accounts for 0.01% of the portfolio, ranked #1157.

Brevan Howard Capital Management first reported a position in CTSH in Q3 2023 and has held it in 9 quarters since. The position peaked at $5.02M in Q4 2025. 985 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

  • Brevan Howard Capital Management held 10,446 shares of Cognizant worth $641K as of Q1 2026.
  • Brevan Howard Capital Management sold 50,060 Cognizant shares in Q1 2026, an estimated $3.58M.
  • Cognizant made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1157 holding.
  • Brevan Howard Capital Management first reported a position in Cognizant in Q3 2023 and has held it in 9 quarters since.
  • Brevan Howard Capital Management's Cognizant position peaked at $5.02M in Q4 2025.
  • 985 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.